
Moderna Inc (NASDAQ:MRNA) shares are trading lower Thursday as vaccine stocks fall in sympathy with Novavax Inc (NASDAQ:NVAX) following reports the FDA's decision on the company's COVID-19 vaccine could be delayed.
According to a CNBC report, citing an agency spokesperson, the FDA needs to review changes to Novavax's manufacturing process before it can authorize the company's vaccine.